P. Merle

发表

A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease

M. Veening, A. Ford, V. Haas, 2018 .

Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid.

G. Ossenkoppele, L. Smit, F. Denkers, 2016, Blood.

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia

G. Ossenkoppele, H. Wessels, S. Zweegman, 2014, Molecular Cytogenetics.

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with b‐cell malignancies

I. Slaper-Cortenbach, P. Merle, E. van Leeuwen, 1994, Cancer.

B precursor acute lymphoblastic leukemia third complementarity‐determining regions predominantly represent an unbiased recombination repertoire: Leukemic transformation frequently occurs in fetal life

C. E. van der Schoot, E. Steenbergen, H. Behrendt, 1994, European journal of immunology.

Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia

J. Berkhof, Q. Waisfisz, M. Heinrich, 2009, Haematologica.

A certi ﬁ ed plasmid reference material for the standardisation of BCR – ABL1 mRNA quanti ﬁ cation by real-time quantitative PCR

D. Colomer, T. Lion, M. Jansson, 2015 .

Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification

G. Ossenkoppele, A. A. van de Loosdrecht, E. Beckhoven, 2010, Leukemia.

A 51‐year‐old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment

H. Berendse, G. Schuurhuis, G. Ossenkoppele, 2009, American journal of hematology.

PCR‐positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B‐cell acute leukaemia

C. E. van der Schoot, I. Slaper-Cortenbach, E. V. van Wering, 1997, British journal of haematology.

DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

B. Löwenberg, J. Cloos, D. Cucchi, 2021, Blood advances.

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody

C. Schoot, I. Slaper-Cortenbach, A. V. D. Borne, 1994 .

Hermansky‐Pudlak syndrome: the importance of molecular subtyping

J. White, M. Huizing, N. Thielen, 2010, Journal of thrombosis and haemostasis : JTH.

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia

G. Ossenkoppele, H. Wessels, S. Zweegman, 2014, Molecular Cytogenetics.

99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin’s lymphoma

R. V. van Oers, E. V. van Royen, I. Slaper-Cortenbach, 1996, Cancer Immunology, Immunotherapy.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

C. E. van der Schoot, I. Slaper-Cortenbach, E. Steenbergen, 1996, British journal of haematology.

Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells

P. Huijgens, J. Zwaginga, S. Zweegman, 2003, Leukemia.

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody.

C. E. van der Schoot, I. Slaper-Cortenbach, A. von dem Borne, 1994, Blood.

DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

F. Kavelaars, P. Merle, M. Rijken, 2021 .